Reporting from Los Angeles…

By the time you read this, I’ll be on a plane.

And on that plane, I will buy the overpriced WiFi and do a deep dive on THREE tickers.

One has to do with a biotech story almost nobody’s talking about…

So let’s talk about it.

The Proteome

Right now, as you read this, your body is manufacturing roughly 20,000 different proteins.

Maybe millions.

They carry oxygen. Fight infection. Repair damaged cells. Transmit signals. Help regulate your mood, your metabolism, your aging clock.

Together, they form something called your proteome.

It's essentially the operating system of your biology—the full working code of everything your body does and everything it's becoming.

Here's what's weird about 2026…

Until recently, we had almost no way to act on it.

We had genetic sequencing. We had blood panels. We had symptoms.

But your proteome—the actual live activity of your biology, right now, in real time—was largely invisible.

That just changed.

A company called LigandForge built an AI that does something that was impossible five years ago: given a specific protein target, it designs therapeutic molecules—peptides—engineered to bind it with precision.

The vision is fully personalized medicine, one molecule per patient per protein. The infrastructure to get there just got a lot closer.

Not the average patient's proteins.

Yours.

It does this at over 1,000 designs per second.

Meaning…

A process that used to take pharmaceutical researchers years and hundreds of millions of dollars—finding a single molecule that binds to a single protein—is now running at machine speed.

And the implications don't stop at medicine.

1,000 Cures Per Second

That changes everything.

The drug industry, as we know it, is already dead. It just doesn't know it yet.

The whole model is: one pill, millions of patients.

That works until you can design a molecule for one patient for less than the cost of a coffee. Then it doesn't work. Then it's over.

Insurance dies too. Insurance is a bet on uncertainty. You don't know if you'll get cancer.

They don't know either.

That's the whole game. But when an AI can read your proteome and say "cardiac event, 2031"—there's no uncertainty left to bet on. The business model evaporates.

Aging becomes a bug you can patch.

That sounds insane.

But aging is just errors accumulating in your cellular code faster than your body repairs them.

If you can see the errors early—fix them early—you’re doing maintenance.

If it works…

I'm not sure anyone’s ready for what that means.

Pension funds. Or estate lawyers. Or anyone who built a plan around the idea that life has a predictable shape.

Depression, schizophrenia, bipolar—these get rewritten too.

We treat them like weather. Something that happens to you.

But they're also proteomic signals. Specific ones. Identifiable ones.

When you cluster enough proteome twins of depressed patients through an AI, you probably don't get one disease called "depression."

You get a bunch of different root causes that all feel the same from the inside—each with a different fix.

The DSM is a list of symptoms. This is a causal map.

Here's the part that actually scares me.

Your Proteome is Crucial

Your proteome twin is the most valuable dataset ever created. It knows what you'll die from. How your brain works at the cellular level. Everything.

Whoever owns that data owns you—or at least owns the most important version of your biology.

China's been building population-scale biological databases for a decade. Most thought it was about cheap genome sequencing. It wasn't.

It was about being ready for exactly this moment.

The country that trains the AI on the biggest, cleanest proteome dataset first wins a generational health advantage that compounds forever.

That race is already underway.

The peptide stocks? The biotech plays? Those are real.

Take them seriously.